Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
26.61 USD | +3.90% | +0.11% | +16.05% |
Kurzporträt
Mitarbeiterzahl: 112
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Peptide-based Therapeutics
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +125.73% |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 27 | 100,0 % | 60 | 100,0 % | +125.73% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01.12.08 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 18.04.22 |
Chief Tech/Sci/R&D Officer | - | 01.07.17 | |
Samuel Saks
CTO | Chief Tech/Sci/R&D Officer | 69 | 24.05.18 |
Arturo Molina
CTO | Chief Tech/Sci/R&D Officer | 65 | 07.11.22 |
Craig Ostroff
LAW | General Counsel | - | - |
Carena Spivey
HRO | Human Resources Officer | - | - |
Suneel Gupta
PRN | Corporate Officer/Principal | 66 | 17.01.19 |
Ashok Bhandari
PRN | Corporate Officer/Principal | - | 01.01.17 |
Carter J. King
PRN | Corporate Officer/Principal | 52 | 01.09.18 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 08.06.17 |
Harold Selick
CHM | Chairman | 69 | 01.02.09 |
Daniel Swisher
BRD | Director/Board Member | 61 | 26.10.23 |
Dinesh Patel
CEO | Chief Executive Officer | 67 | 01.12.08 |
Sarah O'Dowd
BRD | Director/Board Member | 74 | 12.08.20 |
William Waddill
BRD | Director/Board Member | 67 | 01.07.16 |
Bryan Giraudo
BRD | Director/Board Member | 48 | 16.05.18 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 58 274 998 | 56 834 066 ( 97,53 %) | 0 | 97,53 % |
Unternehmenskontakt
Protagonist Therapeutics, Inc.
7707 Gateway Boulevard Suite 140
94560-1160, Newark
+
http://www.protagonist-inc.comSektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+16.05% | 1.55 Mrd. | |
-0.02% | 42.11 Mrd. | |
+45.60% | 40.08 Mrd. | |
+5.04% | 40 Mrd. | |
-11.32% | 26.87 Mrd. | |
+5.25% | 24.58 Mrd. | |
-23.83% | 18.44 Mrd. | |
-1.62% | 11.94 Mrd. | |
+22.75% | 11.66 Mrd. | |
+6.44% | 11.01 Mrd. |
- Börse
- Aktien
- A2AP32 Aktie
- Unternehmen Protagonist Therapeutics, Inc.